Corbus Pharmaceuticals Holdings Inc (CRBP)
17.67
-0.31
(-1.72%)
USD |
NASDAQ |
Nov 27, 13:42
Corbus Pharmaceuticals Holdings Price to Book Value: 1.430 for Nov. 27, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 26, 2024 | 1.455 |
| November 25, 2024 | 1.453 |
| November 22, 2024 | 1.414 |
| November 21, 2024 | 1.354 |
| November 20, 2024 | 1.301 |
| November 19, 2024 | 1.340 |
| November 18, 2024 | 1.356 |
| November 15, 2024 | 1.344 |
| November 14, 2024 | 1.420 |
| November 13, 2024 | 1.470 |
| November 12, 2024 | 1.452 |
| November 11, 2024 | 1.504 |
| November 08, 2024 | 1.520 |
| November 07, 2024 | 1.499 |
| November 06, 2024 | 1.530 |
| November 05, 2024 | 1.550 |
| November 04, 2024 | 1.482 |
| November 01, 2024 | 1.369 |
| October 31, 2024 | 1.292 |
| October 30, 2024 | 1.341 |
| October 29, 2024 | 1.311 |
| October 28, 2024 | 1.322 |
| October 25, 2024 | 1.320 |
| October 24, 2024 | 1.344 |
| October 23, 2024 | 1.343 |
| Date | Value |
|---|---|
| October 22, 2024 | 1.413 |
| October 21, 2024 | 1.43 |
| October 18, 2024 | 1.490 |
| October 17, 2024 | 1.508 |
| October 16, 2024 | 1.548 |
| October 15, 2024 | 1.527 |
| October 14, 2024 | 1.512 |
| October 11, 2024 | 1.520 |
| October 10, 2024 | 1.483 |
| October 09, 2024 | 1.499 |
| October 08, 2024 | 1.585 |
| October 07, 2024 | 1.537 |
| October 04, 2024 | 1.555 |
| October 03, 2024 | 1.611 |
| October 02, 2024 | 1.628 |
| October 01, 2024 | 1.556 |
| September 30, 2024 | 1.670 |
| September 27, 2024 | 2.007 |
| September 26, 2024 | 2.062 |
| September 25, 2024 | 2.048 |
| September 24, 2024 | 1.759 |
| September 23, 2024 | 1.822 |
| September 20, 2024 | 1.872 |
| September 19, 2024 | 4.960 |
| September 18, 2024 | 4.732 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2706
Minimum
Mar 10 2023
95.15
Maximum
Nov 30 2023
10.91
Average
2.762
Median
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 4.944 |
| Perspective Therapeutics Inc | 0.8684 |
| Protalix BioTherapeutics Inc | 3.848 |
| Electromed Inc | 6.226 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 102.71 |
| Price | 17.67 |
| Earnings Yield | -26.43% |
| Market Cap | 215.21M |